Clinical Trials
36 trialsA Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer
OHSU Knight Cancer Institute
Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Conjupro Biotherapeutics, Inc.
NeuroPrevPTSD
Centre Oscar Lambret
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
Nuvation Bio Inc.
Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours
3B Pharmaceuticals GmbH
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
Elevation Oncology
A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors
Seagen Inc.
Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors
Tango Therapeutics, Inc.
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors
Pfizer
ORCHID-1
Medikine, Inc.
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
OHSU Knight Cancer Institute
ICE
Centre Hospitalier Universitaire de Besancon
Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate Cancer
Rutgers, The State University of New Jersey
LODESTAR
pharmaand GmbH
Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE Study
M.D. Anderson Cancer Center
A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors
Genmab
Safety Study of MGD009 in B7-H3-expressing Tumors
MacroGenics
NeoFIND
Advanced Accelerator Applications
Quell Opioid Reduction and Pain Relief in Patients With Cancer
Scripps Translational Science Institute
Pilot Study of (61)CuATSM-PET Imaging in Cancer Patients
University of Wisconsin, Madison
Effect of Cancer Nurse Navigators on Patient Outcomes
University of Wisconsin, Madison
N1
CureOne
111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast Cancer
National Institutes of Health Clinical Center (CC)
HX4 SD
Maastricht Radiation Oncology
Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers
Cota Inc.
A Pilot Trial of Interpersonal Psychotherapy for the Treatment of Depression in Patients With Prostate, Colorectal, Lung and Pancreatic Cancer
New York State Psychiatric Institute
S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer
SWOG Cancer Research Network
A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED)
Merck Sharp & Dohme LLC
Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors
Mirati Therapeutics Inc.
Figitumumab Combined With Pegvisomant For Advanced Solid Tumors
Pfizer
Safety Study of CALAA-01 to Treat Solid Tumor Cancers
Calando Pharmaceuticals
Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo
Auron Healthcare GmbH
Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer
Emory University
Pilot Study of 18F-FLT PET
University of Wisconsin, Madison